Chugai Pharmaceutical
(OTC) CHGCY
Chugai Pharmaceutical Financials at a Glance
Market Cap
$76.92B
Revenue (TTM)
¥1.36T
Net Income (TTM)
¥475.36B
EPS (TTM)
$0.91
P/E Ratio
25.68
Dividend
$0.46
Beta (Volatility)
0.52 (Low)
Dividend
$0.46
Beta (Volatility)
0.52 (Low)
Price
$23.37
Volume
221,848
Open
$23.14
Price
$23.37
Volume
221,848
Open
$23.14
Previous Close
$23.37
Daily Range
$23.03 - $23.39
52-Week Range
$19.50 - $34.84
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.46
Beta (Volatility)
0.52 (Low)
Price
$23.37
Volume
221,848
Open
$23.14
Previous Close
$23.37
Daily Range
$23.03 - $23.39
52-Week Range
$19.50 - $34.84
Estimated Earnings Date
Jul 23, 2026
CHGCY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chugai Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
7,872
CEO
Osamu Okuda
Website
www.chugai-pharm.co.jpHeadquarters
Chuo, SH 103-8324, JP
CHGCY Financials
Key Financial Metrics (TTM)
Gross Margin
71.45%
Operating Margin
47.55%
Net Income Margin
35.02%
Return on Equity
23.16%
Return on Capital
30.14%
Return on Assets
19.96%
Earnings Yield
3.89%
Dividend Yield
1.97%
Payout Ratio
99.07%
Stock Overview
Market Cap
$76.92B
Shares Outstanding
3.29B
Volume
221.85K
Avg. Volume
264.97K
Financials (TTM)
Gross Profit
¥970.13B
Operating Income
¥648.08B
EBITDA
¥699.55B
Operating Cash Flow
¥455.38B
Capital Expenditure
-¥68.19B
Free Cash Flow
¥387.19B
Cash & ST Invst.
¥853.78B
Total Debt
¥17.58B
Chugai Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
¥327.66B
+13.6%
Gross Profit
¥233.16B
+16.2%
Gross Margin
71.16%
N/A
Market Cap
$76.92B
N/A
Market Cap/Employee
$9.77M
N/A
Employees
7,872
N/A
Net Income
¥117.54B
+20.9%
EBITDA
¥174.62B
+27.4%
Quarterly Fundamentals
Total Cash
¥853.78B
-9.6%
Total Debt
¥17.58B
+19990.2%
Accounts Receivable
¥354.47B
+20.3%
Inventory
¥289.54B
+24.2%
Long Term Debt
¥17.58B
N/A
Short Term Debt
¥0.00
N/A
Return on Assets
19.96%
N/A
Return on Invested Capital
31.69%
N/A
Free Cash Flow
¥112.74B
+152.9%
Operating Cash Flow
¥125.67B
+88.5%